Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2003

Hatada EN, Do RK, Orlofsky A, Liou H-, Prystowsky M, Maclennan IC, et al. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J Immunol. 2003;171(2):761-8.

Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla-Favera R, et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 2003;101(10):4115-21.

Scognamiglio T, Hoda RS, Edgar MA, Hoda SA. The need for vigilance in the pathologic evaluation of sentinel lymph nodes: a report of two illustrative cases. Breast J. 2003;9(5):420-2.

Shah NT, Rand JH. Controversies in differentiating thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Mt Sinai J Med. 2003;70(5):344-51.

Rivella S, May C, Chadburn A, Rivière I, Sadelain M. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Blood. 2003;101(8):2932-9.

Zhang J, Zheng N, Zhou P. Exploring the functional complexity of cellular proteins by protein knockout. Proc Natl Acad Sci U S A. 2003;100(24):14127-32.

Sasaki H, Yu C-, Dai M, Tam C, Loda M, Auclair D, et al. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res Treat. 2003;77(3):245-52.

Abécassis V, Jaffrelo L, Rickman D, Aggerbeck L, Herbert C, Truan G, et al. Microarray-based method for combinatorial library sequence mapping and characterization. Biotechniques. 2003;34(6):1272-9.

Chilosi M, Zamò A, Brighenti A, Malpeli G, Montagna L, Piccoli P, et al. Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours. Virchows Arch. 2003;443(2):175-83.

Crowson AN, Magro CM. Atrophying tinea versicolor: a clinical and histological study of 12 patients. Int J Dermatol. 2003;42(12):928-32.